Hypereosinophilic Syndrome and Related Disorders

Displaying 1 - 27 of 27CSV
Masri, A., Bhattacharya, P., Medoff, B., Ejaz, A. U., Elman, M. R., Chandrashekar, P., Ives, L., Santos, A. M., Teruya, S. L., Zhao, Y., Huang, S., Wang, X., Sperry, B. W., Maurer, M. S., Soman, P., & Hanna, M. (2025). A Multicenter Study of Contemporary Long-Term Tafamidis Outcomes in Transthyretin Amyloid Cardiomyopathy. JACC: CardioOncology, 7(3), 282–293. https://doi.org/10.1016/j.jaccao.2024.12.005
Publication Date
Gonzalez-Lopez, E., Maurer, M. S., & Garcia-Pavia, P. (2025). Transthyretin amyloid cardiomyopathy: a paradigm for advancing precision medicine. European Heart Journal. https://doi.org/10.1093/eurheartj/ehae811
Publication Date
Dellon, E. S., Muir, A. B., Katzka, D. A., Shah, S. C., Sauer, B. G., Aceves, S. S., Furuta, G. T., Gonsalves, N., & Hirano, I. (2025). ACG Clinical Guideline: Diagnosis and Management of Eosinophilic Esophagitis. American Journal of Gastroenterology, 120(1), 31–59. https://doi.org/10.14309/ajg.0000000000003194
Publication Date
Hirano, I., Collins, M. H., Katzka, D. A., Mukkada, V. A., Falk, G. W., Terreri, B., Boules, M., Zhang, W., Desai, N. K., & Dellon, E. S. (2024). Effect of Esophageal Dilation History on Efficacy Outcomes in Patients With Eosinophilic Esophagitis Receiving Budesonide Oral Suspension. American Journal of Gastroenterology. https://doi.org/10.14309/ajg.0000000000003197
Publication Date
Adeuyan, O., Trager, M. H., Gordon, E. R., Lapolla, B. A., Schreidah, C. M., Fahmy, L. M., Chen, C., Magro, C. M., & Geskin, L. J. (2024). A unique case of paraneoplastic lymphomatoid Papuloerythroderma of Ofuji with atypical clinical features. JAAD Case Reports, 50, 102–107. https://doi.org/10.1016/j.jdcr.2024.02.009
Publication Date
Song, A., Li, J. Y., Cockey, S. G., Shao, R., & Zhang, H. (2024). EBV‐Positive Pleomorphic Variant Transformation of CD5‐Negative Mantle Cell Lymphoma: A Rare Case Report and Literature Review. Case Reports in Hematology, 2024(1). Portico. https://doi.org/10.1155/2024/3267739
Publication Date
Masuda, M. Y., Pyon, G. C., Luo, H., LeSuer, W. E., Putikova, A., Dao, A., Ortiz, D. R., Schulze, A. R., Fritz, N., Kobayashi, T., Iijima, K., Klein-Szanto, A. J., Shimonosono, M., Flashner, S., Morimoto, M., Pai, R. K., Rank, M. A., Nakagawa, H., Kita, H., … Doyle, A. D. (2024). Epithelial overexpression of IL-33 induces eosinophilic esophagitis dependent on IL-13. Journal of Allergy and Clinical Immunology, 153(5), 1355–1368. https://doi.org/10.1016/j.jaci.2024.01.017
Publication Date
Lee, M. H., Song, A., & Li, J. Y. (2024). Erythroid variant evolving from chronic myeloid leukemia resistant to multiple tyrosine kinase inhibitors: a rare case report. Diagnostic Pathology, 19(1). https://doi.org/10.1186/s13000-024-01446-9
Publication Date
Hughes, M., & Lentzsch, S. (2023). Safety and Efficacy of Subcutaneous Daratumumab in Systemic AL Amyloidosis. Therapeutics and Clinical Risk Management, Volume 19, 1063–1074. https://doi.org/10.2147/tcrm.s325859
Publication Date
Tashi, T., Hermine, O., Castells, M., Guilarte, M., Sabato, V., Maurer, M., Panse, J., Alvarez-Twose, I., Cabral, R., Bird, R., Barete, S., Bouillet, L., Hermans, M., Van Daele, P., González-De-Olano, D., Griffiths, E. A., Jurcic, J., Dybedal, I., Damaj, G. L., … Livideanu, C. B. (2023). Elenestinib, an Investigational, Next Generation KIT D816V Inhibitor, Reduces Mast Cell Burden, Improves Symptoms, and Has a Favorable Safety Profile in Patients with Indolent Systemic Mastocytosis: Analysis of the Harbor Trial. Blood, 142(Supplement 1), 76–76. https://doi.org/10.1182/blood-2023-188904
Publication Date
Orlando, E. H., Gould, P., Cuzzo, B., Ford, M., Chen, Y., Sanjurjo, A., May, B., Tsapepas, D., Leeman-Neill, R. J., Bhagat, G., Dube, G., Morris, H., Arcasoy, S., Latif, F., Martinez, M., Pereira, M., Lipsky, A. H., Sawas, A., Reshef, R., … Amengual, J. E. (2023). The Effect of Preemptive Rituximab Treatment in Patients with EBV Viremia after Solid Organ Transplantation on the Development of Post-Transplant Lymphoproliferative Disorder. Blood, 142(Supplement 1), 990–990. https://doi.org/10.1182/blood-2023-177823
Publication Date
Lapolla, B., Gordon, E., Fahmy, L., Schreidah, C., Adeuyan, O., Magro, C., & Geskin, L. (2023). 214 Angiolymphoid hyperplasia with eosinophilia and kimura disease: a case of clinical and histopathological discrepancy and response to dupilumab. Journal of Investigative Dermatology, 143(11), S368. https://doi.org/10.1016/j.jid.2023.09.222
Publication Date
Yu, Z., Fidler, T. P., Ruan, Y., Vlasschaert, C., Nakao, T., Uddin, M. M., Mack, T., Niroula, A., Heimlich, J. B., Zekavat, S. M., Gibson, C. J., Griffin, G. K., Wang, Y., Peloso, G. M., Heard-Costa, N., Levy, D., Vasan, R. S., Aguet, F., Ardlie, K. G., … Natarajan, P. (2023). Genetic modification of inflammation- and clonal hematopoiesis–associated cardiovascular risk. Journal of Clinical Investigation, 133(18). https://doi.org/10.1172/jci168597
Publication Date
Murthy, G. S. G., Kim, S., Estrada-Merly, N., Abid, M. B., Aljurf, M., Assal, A., Badar, T., Badawy, S. M., Ballen, K., Beitinjaneh, A., Cerny, J., Chhabra, S., DeFilipp, Z., Dholaria, B., Perez, M. A. D., Farhan, S., Freytes, C. O., Gale, R. P., Ganguly, S., … Saber, W. (2023). Association between the choice of the conditioning regimen and outcomes of allogeneic hematopoietic cell transplantation for myelofibrosis. Haematologica, 108(7), 1900–1908. https://doi.org/10.3324/haematol.2022.281958
Publication Date
Hirano, I., Dellon, E. S., Gupta, S. K., Katzka, D. A., Collins, M. H., Wojtowicz, A. M., Terreri, B., Zhang, W., Boules, M., Bhatia, S., & Desai, N. K. (2023). Safety of an investigational formulation of budesonide (budesonide oral suspension) for eosinophilic oesophagitis: an integrated safety analysis of six phase 1–3 clinical trials. Alimentary Pharmacology & Therapeutics, 57(10), 1117–1130. Portico. https://doi.org/10.1111/apt.17430
Publication Date
Salinas, S. A., Mace, E. M., Conte, M. I., Park, C. S., Li, Y., Rosario-Sepulveda, J. I., Mahapatra, S., Moore, E. K., Hernandez, E. R., Chinn, I. K., Reed, A. E., Lee, B. J., Frumovitz, A., Gibbs, R. A., Posey, J. E., Forbes Satter, L. R., Thatayatikom, A., Allenspach, E. J., Wensel, T. G., … Orange, J. S. (2022). An ELF4 hypomorphic variant results in NK cell deficiency. JCI Insight, 7(23). https://doi.org/10.1172/jci.insight.155481
Publication Date
Brannagan, T. H., Coelho, T., Wang, A. K., Polydefkis, M. J., Dyck, P. J., Berk, J. L., Drachman, B., Gorevic, P., Whelan, C., Conceição, I., Plante-Bordeneuve, V., Merlini, G., Obici, L., Plana, J. M. C., Gamez, J., Kristen, A. V., Mazzeo, A., Gentile, L., … Narayana, A. (2022). Long-term efficacy and safety of inotersen for hereditary transthyretin amyloidosis: NEURO-TTR open-label extension 3-year update. Journal of Neurology, 269(12), 6416–6427. https://doi.org/10.1007/s00415-022-11276-8
Publication Date
DeAngelo, D. J., Pullarkat, V. A., Piris-Villaespesa, M., George, T. I., Patel, J. L., Ustun, C., Bose, P., Heaney, M. L., Sachs, J., Sun, L., Pilla, A., Exter, B., Jolin, H. A., & Tashi, T. (2022). Preliminary Safety and Efficacy from Apex, a Phase 2 Study of Bezuclastinib (CGT9486), a Novel, Highly Selective, Potent KIT D816V Tyrosine Kinase Inhibitor, in Adults with Advanced Systemic Mastocytosis (AdvSM). Blood, 140(Supplement 1), 1512–1513. https://doi.org/10.1182/blood-2022-156311
Publication Date
Gonzalez-Lopez, E., Escobar-Lopez, L., Obici, L., Saturi, G., Bezard, M., Saith, S. E., AbouEzzeddine, O. F., Mussinelli, R., Gagliardi, C., Kharoubi, M., Griffin, J. M., Dispenzieri, A., Vilches, S., Perlini, S., Longhi, S., Oghina, S., Rivas, A., Grogan, M., Maurer, M. S., … Garcia-Pavia, P. (2022). Prognosis of Transthyretin Cardiac Amyloidosis Without Heart Failure Symptoms. JACC: CardioOncology, 4(4), 442–454. https://doi.org/10.1016/j.jaccao.2022.07.007
Publication Date
Dellon, E. S., Gonsalves, N., Abonia, J. P., Alexander, J. A., Arva, N. C., Atkins, D., Attwood, S. E., Auth, M. K. H., Bailey, D. D., Biederman, L., Blanchard, C., Bonis, P. A., Bose, P., Bredenoord, A. J., Chang, J. W., Chehade, M., Collins, M. H., Di Lorenzo, C., Dias, J. A., … Aceves, S. S. (2022). International Consensus Recommendations for Eosinophilic Gastrointestinal Disease Nomenclature. Clinical Gastroenterology and Hepatology, 20(11), 2474-2484.e3. https://doi.org/10.1016/j.cgh.2022.02.017
Publication Date
Nathanson, J. T., Chawla, S., Blackett, J., & Garcia-Carrasquillo, R. J. (2022). S2307 Esophageal Hemorrhage After Transesophageal Echocardiography in a Patient With Undiagnosed Eosinophilic Esophagitis. American Journal of Gastroenterology, 117(10S), e1553–e1553. https://doi.org/10.14309/01.ajg.0000865868.81054.8f
Publication Date
Tran, P., Gober, L., Garabedian, E. K., Fuleihan, R. L., Puck, J. M., Sullivan, K. E., Spergel, J. M., & Ruffner, M. A. (2022). Eosinophilic gastrointestinal disorders in patients with inborn errors of immunity: Data from the USIDNET registry. Frontiers in Immunology, 13. https://doi.org/10.3389/fimmu.2022.987895
Publication Date
Westin, O., Fosbøl, E. L., Maurer, M. S., Leicht, B. P., Hasbak, P., Mylin, A. K., Rørvig, S., Lindkær, T. H., Johannesen, H. H., & Gustafsson, F. (2022). Screening for Cardiac Amyloidosis 5 to 15 Years After Surgery for Bilateral Carpal Tunnel Syndrome. Journal of the American College of Cardiology, 80(10), 967–977. https://doi.org/10.1016/j.jacc.2022.06.026
Publication Date

DeAngelo, D. J., Pullarkat, V., Piris-Villaespesa, M., George, T. I., Patel, J. L., Ustun, C., Bose, P., Heaney, M. L., Pilla, A., Massaro, M., Exter, B., Jolin, H. A., Mikhak, Z., & Tashi, T. (2022). P1049: A Phase 2 Study of Bezuclastinib (CGT9486), a Novel, Highly Selective, Potent Kit D816V Inhibitor, in Adults With Advanced Systemic Mastocytosis (Apex): Methods, Baseline Data, and Early Insights. HemaSphere, 6, 939–940. https://doi.org/10.1097/01.hs9.0000847064.38588.9b

Publication Date
Fichadiya, H., Noori, M. A. M., Patel, B. D., Bhavsar, M., Visveswaran, G. K., Sommer, R. J., & Joshi, M. (2022). A RARE CASE OF MULTIPLE PULMONARY VEIN STENOSIS ASSOCIATED WITH DERMATOMYOSITIS. Journal of the American College of Cardiology, 79(9), 3197. https://doi.org/10.1016/s0735-1097(22)04188-2
Publication Date
Hara, T., Kasagi, Y., Wang, J., Sasaki, M., Aaron, B., Karami, A., Shimonosono, M., Shimonosono, R., Maekawa, H., Dolinsky, L., Wilkins, B., Klein, J., Wei, J., Nunes, K., Lynch, K., Spergel, J. M., Hamilton, K. E., Ruffner, M. A., Karakasheva, T. A., … Muir, A. B. (2022). CD73+ Epithelial Progenitor Cells That Contribute to Homeostasis and Renewal Are Depleted in Eosinophilic Esophagitis. Cellular and Molecular Gastroenterology and Hepatology, 13(5), 1449–1467. https://doi.org/10.1016/j.jcmgh.2022.01.018
Publication Date
Gotlib, J., Reiter, A., Radia, D. H., Deininger, M. W., George, T. I., Panse, J., Vannucchi, A. M., Platzbecker, U., Alvarez-Twose, I., Mital, A., Hermine, O., Dybedal, I., Hexner, E. O., Hicks, L. K., Span, L., Mesa, R., Bose, P., Pettit, K. M., Heaney, M. L., … DeAngelo, D. J. (2021). Efficacy and safety of avapritinib in advanced systemic mastocytosis: interim analysis of the phase 2 PATHFINDER trial. Nature Medicine, 27(12), 2192–2199. https://doi.org/10.1038/s41591-021-01539-8
Publication Date